Pelthos Therapeutics Inc. logo

PTHSPelthos Therapeutics Inc.

PTHS Stock Price, Valuation & Chart | Pelthos Therapeutics Inc.

Compare

PTHS Historical price chart

PTHS Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization87.00M
PE Ratio-1.51
EPS-16.6
Trading Volume87.88K
Today's High/Low26.1/23.26
Dividend Yield0.00
52 Week High/Low37.5/18.19
Shares Outstanding3.48M
PTHS Financial Statement
PTHS Analyst ratings
PTHS Analysis & performance metrics

PTHS Company profile

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers…

PTHS Management team

Management
Francis Knuettel II, M.B.A.CFO
Chief Financial Officer
Sai Rangarao M.B.A.
Chief Commercial Officer
Scott M. PleshaCEO
Chief Executive Officer, President & Director
Total 3 executives

PTHS Frequently asked questions

What is Pelthos Therapeutics Inc. (PTHS) Stock Price?

Current stock price of Pelthos Therapeutics Inc. (PTHS) stock is $25.030. The stock price is +0.85% higher in the session. The intraday range can be seen from this page. Volume of Pelthos Therapeutics Inc. (PTHS) stock is 87.88K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Pelthos Therapeutics Inc. (PTHS) stock price going up or down today?

The stock price of Pelthos Therapeutics Inc. (PTHS) can change with earnings, company news, and overall market sentiment. Pelthos Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Pelthos Therapeutics Inc. stock expensive at its current price?

Whether Pelthos Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PTHS on this page is -1.51. EPS on this page is -16.60. Compare those figures with peers and growth expectations before deciding if the current Pelthos Therapeutics Inc. price is justified.

How has the stock price of Pelthos Therapeutics Inc. (PTHS) performed historically?

Historical performance for Pelthos Therapeutics Inc. (PTHS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PTHS reacted to past earnings and market events.

Should I buy Pelthos Therapeutics Inc. (PTHS) stock, at this price?

Buying Pelthos Therapeutics Inc. (PTHS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.